These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 187795)

  • 1. Inefficient humoral immune response of lymphoma-prone wild mice to persistent leukemia virus infection.
    Klement V; Gardner MB; Henderson BE; Ihle JN; Stanley AG; Gilden RV; Estes JD
    J Natl Cancer Inst; 1976 Nov; 57(5):1169-73. PubMed ID: 187795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
    Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Each T-cell lymphoma induced by a particular murine leukemia virus bears surface receptors specific for that virus.
    McGrath M; Weissman IL; Baird S; Raschke W; Decleve A; Lieberman M; Kaplan HS
    Birth Defects Orig Artic Ser; 1978; 14(2):349-61. PubMed ID: 76488
    [No Abstract]   [Full Text] [Related]  

  • 4. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously.
    Sinkovics JG
    Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The apparent lack of association of antibody activity to murine leukemia virus and lymphoma development in (AKR x CBA) F1 mice.
    Barnes RD; Tuffrey M; Holmes HC
    Eur J Cancer (1965); 1981 Jan; 17(1):93-8. PubMed ID: 6266833
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent studies on the role of the immune response in resistance to virus-induced leukemias and lymphomas.
    Meruelo D; McDevitt HO
    Semin Hematol; 1978 Oct; 15(4):399-419. PubMed ID: 216115
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of reactivities of natural antibodies to endogenous RNA tumor virus envelope antigens and virus-induced cell surface antigens.
    Hanna MG; Ihle JN; Batzing BL; Tennant TW; Schenley CK
    Cancer Res; 1975 Jan; 35(1):164-71. PubMed ID: 45890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of paralysis and suppression of lymphoma in wild mice by passive immunization to congenitally transmitted murine leukemia virus.
    Gardner MB; Estes JD; Casagrande J; Rasheed S
    J Natl Cancer Inst; 1980 Feb; 64(2):359-64. PubMed ID: 6243718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation leukemia in C57BL/6 mice. I. Lack of serological evidence for the role of endogenous ecotropic viruses in pathogenesis.
    Ihle JN; McEwan R; Bengali K
    J Exp Med; 1976 Dec; 144(6):1391-405. PubMed ID: 63528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged E55+ retrovirus expression in aged mice is associated with a decline in the anti-virus immune response.
    elRefaei M; Blank KJ; Murasko DM
    Virology; 2001 Nov; 290(2):281-9. PubMed ID: 11883192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autogenous immunity to endogenous RNA tumor virus. Radioimmune precipitation assay of mouse serum antibody levels.
    Ihle JN; Yurconic M; Hanna MG
    J Exp Med; 1973 Jul; 138(1):194-208. PubMed ID: 4352105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further implication of murine leukemia-like virs in the disorders of NZB mice.
    Mellors RC; Aoki T; Huebner RJ
    J Exp Med; 1969 May; 129(5):1045-62. PubMed ID: 4305180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital transmission of murine leukemia virus from wild mice prone to the development of lymphoma and paralysis.
    Gardner MB; Chiri A; Dougherty MF; Casagrande J; Estes JD
    J Natl Cancer Inst; 1979 Jan; 62(1):63-70. PubMed ID: 214610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes.
    Iezzi G; Rivolta L; Ronchetti A; Martin-Fontecha A; Rosato A; Protti MP; Sabbadini MG; Bellone M
    Cancer Res; 1997 Jul; 57(13):2564-8. PubMed ID: 9205054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
    Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
    Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression in mice after inoculation with 334C, a murine lymphatic leukemia-inducing virus.
    Schenk PJ; Buffett RF
    J Natl Cancer Inst; 1977 Mar; 58(3):665-71. PubMed ID: 190412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural antilymphoma antibodies in C3Hf mice serum: lack of identity with autoimmune and anti murine leukemia virus antibodies.
    Boiocchi M; Pierotti MA; Ménard S; Miotti S; Colnaghi MI
    Tumori; 1979 Aug; 65(4):435-46. PubMed ID: 227151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the immune response in MULV-induced lymphomagenesis.
    Marshall DJ; Gaulton GN
    Leukemia; 1996 Dec; 10(12):1860-6. PubMed ID: 8946922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse leukemia virus activation by chemical carcinogens.
    Igel HJ; Huebner RJ; Turner HC; Kotin P; Falk HL
    Science; 1969 Dec; 166(3913):1624-6. PubMed ID: 4311011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement and tumor antibody levels in cats, and changes associated with natural feline leukemia virus infection and malignant disease.
    Grant CK; Pickard DK; Ramaika C; Madewell BR; Essex M
    Cancer Res; 1979 Jan; 39(1):75-81. PubMed ID: 216484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.